カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ガチフロキサシンの世界市場見通し2023年-2029年

◆英語タイトル：Gatifloxacin Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5580）

◆商品コード：MMG23JU5580
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Gatifloxacin Market 調査レポートは次の情報を含め、グローバルにおけるのガチフロキサシン市場規模と予測を収録しています。・世界のガチフロキサシン市場：売上、2018年-2023年、2024年-2029年
・世界のガチフロキサシン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のガチフロキサシン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ガチフロキサシンのグローバル主要企業は、Pacific Pharma、 Apotex、 Sandoz、 Allergan、 Bristol-Myers Squibb、 Mylan、 Hi Tech Pharmacal、 Lupin Pharmaceuticals、 Teva Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ガチフロキサシンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のガチフロキサシン市場：タイプ別、2018年-2023年、2024年-2029年
世界のガチフロキサシン市場：タイプ別市場シェア、2022年
・錠剤、水溶液、カプセル、その他

世界のガチフロキサシン市場：用途別、2018年-2023年、2024年-2029年
世界のガチフロキサシン市場：用途別市場シェア、2022年
・合成抗菌剤、眼科薬、その他

世界のガチフロキサシン市場：地域・国別、2018年-2023年、2024年-2029年
世界のガチフロキサシン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるガチフロキサシンのグローバル売上、2018年-2023年
・主要企業におけるガチフロキサシンのグローバル売上シェア、2022年
・主要企業におけるガチフロキサシンのグローバル販売量、2018年-2023年
・主要企業におけるガチフロキサシンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pacific Pharma、 Apotex、 Sandoz、 Allergan、 Bristol-Myers Squibb、 Mylan、 Hi Tech Pharmacal、 Lupin Pharmaceuticals、 Teva Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
ガチフロキサシン市場の定義
市場セグメント
世界のガチフロキサシン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のガチフロキサシン市場規模
世界のガチフロキサシン市場規模：2022年 VS 2029年
世界のガチフロキサシン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのガチフロキサシンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のガチフロキサシン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：錠剤、水溶液、カプセル、その他
ガチフロキサシンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：合成抗菌剤、眼科薬、その他
ガチフロキサシンの用途別グローバル売上・予測

・地域別市場分析
地域別ガチフロキサシン市場規模 2022年と2029年
地域別ガチフロキサシン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pacific Pharma、 Apotex、 Sandoz、 Allergan、 Bristol-Myers Squibb、 Mylan、 Hi Tech Pharmacal、 Lupin Pharmaceuticals、 Teva Pharmaceuticals
...

Gatifloxacin is a racemic compound of 8-methoxyfluoroquinolone. It has a broad spectrum of activity against Gram-negative and positive microorganisms in vitro, and its R- and S-enantiomer antibacterial activities are the same. The antibacterial effect of this product is to inhibit bacterial DNA gyrase and topoisomerase IV, thereby inhibiting bacterial DNA replication, transcription and repair processes.
This report aims to provide a comprehensive presentation of the global market for Gatifloxacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gatifloxacin. This report contains market size and forecasts of Gatifloxacin in global, including the following market information:
Global Gatifloxacin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gatifloxacin Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gatifloxacin companies in 2022 (%)
The global Gatifloxacin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gatifloxacin include Pacific Pharma, Apotex, Sandoz, Allergan, Bristol-Myers Squibb, Mylan, Hi Tech Pharmacal, Lupin Pharmaceuticals and Teva Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gatifloxacin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gatifloxacin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gatifloxacin Market Segment Percentages, by Type, 2022 (%)
Tablet
Aqueous Solution
Capsule
Others
Global Gatifloxacin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gatifloxacin Market Segment Percentages, by Application, 2022 (%)
Synthetic Antibacterial
Ophthalmic Medicine
Other
Global Gatifloxacin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gatifloxacin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gatifloxacin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gatifloxacin revenues share in global market, 2022 (%)
Key companies Gatifloxacin sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gatifloxacin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pacific Pharma
Apotex
Sandoz
Allergan
Bristol-Myers Squibb
Mylan
Hi Tech Pharmacal
Lupin Pharmaceuticals
Teva Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gatifloxacin, market overview.
Chapter 2: Global Gatifloxacin market size in revenue and volume.
Chapter 3: Detailed analysis of Gatifloxacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gatifloxacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gatifloxacin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Gatifloxacin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gatifloxacin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gatifloxacin Overall Market Size
2.1 Global Gatifloxacin Market Size: 2022 VS 2029
2.2 Global Gatifloxacin Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gatifloxacin Sales: 2018-2029
3 Company Landscape
3.1 Top Gatifloxacin Players in Global Market
3.2 Top Global Gatifloxacin Companies Ranked by Revenue
3.3 Global Gatifloxacin Revenue by Companies
3.4 Global Gatifloxacin Sales by Companies
3.5 Global Gatifloxacin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gatifloxacin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gatifloxacin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gatifloxacin Players in Global Market
3.8.1 List of Global Tier 1 Gatifloxacin Companies
3.8.2 List of Global Tier 2 and Tier 3 Gatifloxacin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gatifloxacin Market Size Markets, 2022 & 2029
4.1.2 Tablet
4.1.3 Aqueous Solution
4.1.4 Capsule
4.1.5 Others
4.2 By Type – Global Gatifloxacin Revenue & Forecasts
4.2.1 By Type – Global Gatifloxacin Revenue, 2018-2023
4.2.2 By Type – Global Gatifloxacin Revenue, 2024-2029
4.2.3 By Type – Global Gatifloxacin Revenue Market Share, 2018-2029
4.3 By Type – Global Gatifloxacin Sales & Forecasts
4.3.1 By Type – Global Gatifloxacin Sales, 2018-2023
4.3.2 By Type – Global Gatifloxacin Sales, 2024-2029
4.3.3 By Type – Global Gatifloxacin Sales Market Share, 2018-2029
4.4 By Type – Global Gatifloxacin Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gatifloxacin Market Size, 2022 & 2029
5.1.2 Synthetic Antibacterial
5.1.3 Ophthalmic Medicine
5.1.4 Other
5.2 By Application – Global Gatifloxacin Revenue & Forecasts
5.2.1 By Application – Global Gatifloxacin Revenue, 2018-2023
5.2.2 By Application – Global Gatifloxacin Revenue, 2024-2029
5.2.3 By Application – Global Gatifloxacin Revenue Market Share, 2018-2029
5.3 By Application – Global Gatifloxacin Sales & Forecasts
5.3.1 By Application – Global Gatifloxacin Sales, 2018-2023
5.3.2 By Application – Global Gatifloxacin Sales, 2024-2029
5.3.3 By Application – Global Gatifloxacin Sales Market Share, 2018-2029
5.4 By Application – Global Gatifloxacin Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gatifloxacin Market Size, 2022 & 2029
6.2 By Region – Global Gatifloxacin Revenue & Forecasts
6.2.1 By Region – Global Gatifloxacin Revenue, 2018-2023
6.2.2 By Region – Global Gatifloxacin Revenue, 2024-2029
6.2.3 By Region – Global Gatifloxacin Revenue Market Share, 2018-2029
6.3 By Region – Global Gatifloxacin Sales & Forecasts
6.3.1 By Region – Global Gatifloxacin Sales, 2018-2023
6.3.2 By Region – Global Gatifloxacin Sales, 2024-2029
6.3.3 By Region – Global Gatifloxacin Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gatifloxacin Revenue, 2018-2029
6.4.2 By Country – North America Gatifloxacin Sales, 2018-2029
6.4.3 US Gatifloxacin Market Size, 2018-2029
6.4.4 Canada Gatifloxacin Market Size, 2018-2029
6.4.5 Mexico Gatifloxacin Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gatifloxacin Revenue, 2018-2029
6.5.2 By Country – Europe Gatifloxacin Sales, 2018-2029
6.5.3 Germany Gatifloxacin Market Size, 2018-2029
6.5.4 France Gatifloxacin Market Size, 2018-2029
6.5.5 U.K. Gatifloxacin Market Size, 2018-2029
6.5.6 Italy Gatifloxacin Market Size, 2018-2029
6.5.7 Russia Gatifloxacin Market Size, 2018-2029
6.5.8 Nordic Countries Gatifloxacin Market Size, 2018-2029
6.5.9 Benelux Gatifloxacin Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gatifloxacin Revenue, 2018-2029
6.6.2 By Region – Asia Gatifloxacin Sales, 2018-2029
6.6.3 China Gatifloxacin Market Size, 2018-2029
6.6.4 Japan Gatifloxacin Market Size, 2018-2029
6.6.5 South Korea Gatifloxacin Market Size, 2018-2029
6.6.6 Southeast Asia Gatifloxacin Market Size, 2018-2029
6.6.7 India Gatifloxacin Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gatifloxacin Revenue, 2018-2029
6.7.2 By Country – South America Gatifloxacin Sales, 2018-2029
6.7.3 Brazil Gatifloxacin Market Size, 2018-2029
6.7.4 Argentina Gatifloxacin Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gatifloxacin Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gatifloxacin Sales, 2018-2029
6.8.3 Turkey Gatifloxacin Market Size, 2018-2029
6.8.4 Israel Gatifloxacin Market Size, 2018-2029
6.8.5 Saudi Arabia Gatifloxacin Market Size, 2018-2029
6.8.6 UAE Gatifloxacin Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pacific Pharma
7.1.1 Pacific Pharma Company Summary
7.1.2 Pacific Pharma Business Overview
7.1.3 Pacific Pharma Gatifloxacin Major Product Offerings
7.1.4 Pacific Pharma Gatifloxacin Sales and Revenue in Global (2018-2023)
7.1.5 Pacific Pharma Key News & Latest Developments
7.2 Apotex
7.2.1 Apotex Company Summary
7.2.2 Apotex Business Overview
7.2.3 Apotex Gatifloxacin Major Product Offerings
7.2.4 Apotex Gatifloxacin Sales and Revenue in Global (2018-2023)
7.2.5 Apotex Key News & Latest Developments
7.3 Sandoz
7.3.1 Sandoz Company Summary
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Gatifloxacin Major Product Offerings
7.3.4 Sandoz Gatifloxacin Sales and Revenue in Global (2018-2023)
7.3.5 Sandoz Key News & Latest Developments
7.4 Allergan
7.4.1 Allergan Company Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Gatifloxacin Major Product Offerings
7.4.4 Allergan Gatifloxacin Sales and Revenue in Global (2018-2023)
7.4.5 Allergan Key News & Latest Developments
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Summary
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb Gatifloxacin Major Product Offerings
7.5.4 Bristol-Myers Squibb Gatifloxacin Sales and Revenue in Global (2018-2023)
7.5.5 Bristol-Myers Squibb Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Gatifloxacin Major Product Offerings
7.6.4 Mylan Gatifloxacin Sales and Revenue in Global (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Hi Tech Pharmacal
7.7.1 Hi Tech Pharmacal Company Summary
7.7.2 Hi Tech Pharmacal Business Overview
7.7.3 Hi Tech Pharmacal Gatifloxacin Major Product Offerings
7.7.4 Hi Tech Pharmacal Gatifloxacin Sales and Revenue in Global (2018-2023)
7.7.5 Hi Tech Pharmacal Key News & Latest Developments
7.8 Lupin Pharmaceuticals
7.8.1 Lupin Pharmaceuticals Company Summary
7.8.2 Lupin Pharmaceuticals Business Overview
7.8.3 Lupin Pharmaceuticals Gatifloxacin Major Product Offerings
7.8.4 Lupin Pharmaceuticals Gatifloxacin Sales and Revenue in Global (2018-2023)
7.8.5 Lupin Pharmaceuticals Key News & Latest Developments
7.9 Teva Pharmaceuticals
7.9.1 Teva Pharmaceuticals Company Summary
7.9.2 Teva Pharmaceuticals Business Overview
7.9.3 Teva Pharmaceuticals Gatifloxacin Major Product Offerings
7.9.4 Teva Pharmaceuticals Gatifloxacin Sales and Revenue in Global (2018-2023)
7.9.5 Teva Pharmaceuticals Key News & Latest Developments
8 Global Gatifloxacin Production Capacity, Analysis
8.1 Global Gatifloxacin Production Capacity, 2018-2029
8.2 Gatifloxacin Production Capacity of Key Manufacturers in Global Market
8.3 Global Gatifloxacin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gatifloxacin Supply Chain Analysis
10.1 Gatifloxacin Industry Value Chain
10.2 Gatifloxacin Upstream Market
10.3 Gatifloxacin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gatifloxacin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Gatifloxacin in Global Market
Table 2. Top Gatifloxacin Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gatifloxacin Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gatifloxacin Revenue Share by Companies, 2018-2023
Table 5. Global Gatifloxacin Sales by Companies, (K Units), 2018-2023
Table 6. Global Gatifloxacin Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gatifloxacin Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gatifloxacin Product Type
Table 9. List of Global Tier 1 Gatifloxacin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gatifloxacin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Gatifloxacin Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gatifloxacin Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gatifloxacin Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gatifloxacin Sales (K Units), 2018-2023
Table 15. By Type - Global Gatifloxacin Sales (K Units), 2024-2029
Table 16. By Application – Global Gatifloxacin Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gatifloxacin Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gatifloxacin Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gatifloxacin Sales (K Units), 2018-2023
Table 20. By Application - Global Gatifloxacin Sales (K Units), 2024-2029
Table 21. By Region – Global Gatifloxacin Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gatifloxacin Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gatifloxacin Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gatifloxacin Sales (K Units), 2018-2023
Table 25. By Region - Global Gatifloxacin Sales (K Units), 2024-2029
Table 26. By Country - North America Gatifloxacin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gatifloxacin Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gatifloxacin Sales, (K Units), 2018-2023
Table 29. By Country - North America Gatifloxacin Sales, (K Units), 2024-2029
Table 30. By Country - Europe Gatifloxacin Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gatifloxacin Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gatifloxacin Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gatifloxacin Sales, (K Units), 2024-2029
Table 34. By Region - Asia Gatifloxacin Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gatifloxacin Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gatifloxacin Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gatifloxacin Sales, (K Units), 2024-2029
Table 38. By Country - South America Gatifloxacin Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gatifloxacin Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gatifloxacin Sales, (K Units), 2018-2023
Table 41. By Country - South America Gatifloxacin Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Gatifloxacin Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gatifloxacin Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gatifloxacin Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gatifloxacin Sales, (K Units), 2024-2029
Table 46. Pacific Pharma Company Summary
Table 47. Pacific Pharma Gatifloxacin Product Offerings
Table 48. Pacific Pharma Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pacific Pharma Key News & Latest Developments
Table 50. Apotex Company Summary
Table 51. Apotex Gatifloxacin Product Offerings
Table 52. Apotex Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Apotex Key News & Latest Developments
Table 54. Sandoz Company Summary
Table 55. Sandoz Gatifloxacin Product Offerings
Table 56. Sandoz Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sandoz Key News & Latest Developments
Table 58. Allergan Company Summary
Table 59. Allergan Gatifloxacin Product Offerings
Table 60. Allergan Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Allergan Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Gatifloxacin Product Offerings
Table 64. Bristol-Myers Squibb Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Mylan Company Summary
Table 67. Mylan Gatifloxacin Product Offerings
Table 68. Mylan Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Mylan Key News & Latest Developments
Table 70. Hi Tech Pharmacal Company Summary
Table 71. Hi Tech Pharmacal Gatifloxacin Product Offerings
Table 72. Hi Tech Pharmacal Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Hi Tech Pharmacal Key News & Latest Developments
Table 74. Lupin Pharmaceuticals Company Summary
Table 75. Lupin Pharmaceuticals Gatifloxacin Product Offerings
Table 76. Lupin Pharmaceuticals Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Lupin Pharmaceuticals Key News & Latest Developments
Table 78. Teva Pharmaceuticals Company Summary
Table 79. Teva Pharmaceuticals Gatifloxacin Product Offerings
Table 80. Teva Pharmaceuticals Gatifloxacin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Teva Pharmaceuticals Key News & Latest Developments
Table 82. Gatifloxacin Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Gatifloxacin Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Gatifloxacin Production by Region, 2018-2023 (K Units)
Table 85. Global Gatifloxacin Production by Region, 2024-2029 (K Units)
Table 86. Gatifloxacin Market Opportunities & Trends in Global Market
Table 87. Gatifloxacin Market Drivers in Global Market
Table 88. Gatifloxacin Market Restraints in Global Market
Table 89. Gatifloxacin Raw Materials
Table 90. Gatifloxacin Raw Materials Suppliers in Global Market
Table 91. Typical Gatifloxacin Downstream
Table 92. Gatifloxacin Downstream Clients in Global Market
Table 93. Gatifloxacin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gatifloxacin Segment by Type in 2022
Figure 2. Gatifloxacin Segment by Application in 2022
Figure 3. Global Gatifloxacin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gatifloxacin Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gatifloxacin Revenue, 2018-2029 (US$, Mn)
Figure 7. Gatifloxacin Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gatifloxacin Revenue in 2022
Figure 9. By Type - Global Gatifloxacin Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gatifloxacin Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gatifloxacin Sales Market Share, 2018-2029
Figure 12. By Type - Global Gatifloxacin Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Gatifloxacin Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gatifloxacin Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gatifloxacin Sales Market Share, 2018-2029
Figure 16. By Application - Global Gatifloxacin Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Gatifloxacin Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gatifloxacin Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gatifloxacin Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gatifloxacin Sales Market Share, 2018-2029
Figure 21. By Country - North America Gatifloxacin Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gatifloxacin Sales Market Share, 2018-2029
Figure 23. US Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gatifloxacin Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gatifloxacin Sales Market Share, 2018-2029
Figure 28. Germany Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 29. France Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gatifloxacin Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gatifloxacin Sales Market Share, 2018-2029
Figure 37. China Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 41. India Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gatifloxacin Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gatifloxacin Sales Market Share, 2018-2029
Figure 44. Brazil Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gatifloxacin Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gatifloxacin Sales Market Share, 2018-2029
Figure 48. Turkey Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gatifloxacin Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gatifloxacin Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Gatifloxacin by Region, 2022 VS 2029
Figure 54. Gatifloxacin Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ガチフロキサシンの世界市場見通し2023年-2029年(Gatifloxacin Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ガチフロキサシンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp